SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

NPPA fixes retail price of 42 formulations, revise prices based on review orders: Our Bureau, New Delhi Tuesday, February 11, 2025, 13:30 Hrs [IST] The National Pharmaceutical Pri ...

Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...

New research from the University of Birmingham and Aston University has found that putting lower-calorie meal choices at the ...

The US government has published the finalised 'maximum fair prices' (MFPs) for the first 10 medicines subject to Medicare negotiations under the Inflation Reduction Act (IRA), shortly after ...

Net interest income was 14% higher YoY, at ₹587.7 crore, due to steady loan growth & higher interest margins than Q3 FY24 levels of ₹516 crore.

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Ramadan is a blessed month in the Muslim calendar. It is obligatory for Muslims to observe fast this month. Every year, I ...